JPMorgan foresees shares of Ionis Pharmaceuticals rising another 16% from their Tuesday close after a 170% runup in six months.
How small and big investors are picking AI winners
Frank Holland breaks down what traders are watching ahead of the new session.
Stay away from FedEx as competition heats up and macro headwinds mount, says JPMorgan
JPMorgan is moving to the sidelines when it comes to FedEx.
Guggenheim says this little-known cancer stock can more than double from here
Guggenheim applauded CC Oncology’s immunotherapy development and “potentially attractive catalyst path.”
Morgan Stanley highlights stocks that could see big earnings surprises this quarter
Morgan Stanley highlighted companies such as Roblox and Reddit that could surprise investors to the upside as third quarter earnings are reported.
A bubble may be forming, but there are still good investment opportunities in this market, says Josh Brown
Some AI stocks are vastly overvalued, suggesting there’s a bubble, but that shouldn’t deter pouring new money into good projects, Josh Brown told CNBC.
Goldman Sachs portfolio manager Brook Dane lists Nvidia, TSMC among top AI stocks to buy
Although Nvidia is trading at all-time highs, Goldman Sachs’ Brook Dane said the stock doesn’t look “extended.”
This crypto-related stock is setting up for a major move higher, according to the charts
Todd Gordon breaks down the technical outlook for this crypto stock.
Bank of America sticks by DraftKings, Flutter as prediction market competition ramps up
“The battle, for a new and much larger market is just beginning,” analyst Shaun Kelley said.
PepsiCo shares have struggled against Coca-Cola. That may change after earnings Thursday
Jay Woods breaks down the charts on PepsiCo into results Thursday before the bell.